Total Payments
$71,608
2024 Payments
$166.96
Companies
27
Transactions
654
Medicare Patients
17,452
Medicare Billing
$1.9M
Payment Breakdown by Category
Other$57,550 (80.4%)
Food & Beverage$12,054 (16.8%)
Travel$1,334 (1.9%)
Consulting$634.00 (0.9%)
Education$35.84 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $57,550 | 26 | 80.4% |
| Food and Beverage | $12,054 | 619 | 16.8% |
| Travel and Lodging | $1,334 | 3 | 1.9% |
| Consulting Fee | $634.00 | 2 | 0.9% |
| Education | $35.84 | 4 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $50,177 | 276 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $13,385 | 57 | $0 (2023) |
| Medtronic Vascular, Inc. | $1,884 | 11 | $0 (2019) |
| BIOTRONIK INC. | $1,219 | 24 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,024 | 55 | $0 (2022) |
| Abbott Laboratories | $550.87 | 9 | $0 (2022) |
| PFIZER INC. | $465.06 | 63 | $0 (2023) |
| Amgen Inc. | $426.87 | 27 | $0 (2023) |
| Boston Scientific Corporation | $393.69 | 8 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $346.23 | 45 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $166.96 | 4 | Janssen Pharmaceuticals, Inc ($125.00) |
| 2023 | $546.18 | 19 | Boston Scientific Corporation ($179.78) |
| 2022 | $2,020 | 112 | Janssen Pharmaceuticals, Inc ($392.28) |
| 2021 | $1,515 | 70 | Janssen Pharmaceuticals, Inc ($430.35) |
| 2020 | $968.95 | 40 | Janssen Pharmaceuticals, Inc ($483.91) |
| 2019 | $28,435 | 154 | Janssen Pharmaceuticals, Inc ($19,281) |
| 2018 | $21,115 | 131 | Janssen Pharmaceuticals, Inc ($13,323) |
| 2017 | $16,841 | 124 | Janssen Pharmaceuticals, Inc ($15,976) |
All Payment Transactions
654 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/05/2024 | Boston Scientific Corporation | LUX-Dx Insertable Cardiac Monitor (Device) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: LUX-Dx_CRM | ||||||
| 09/26/2024 | Boston Scientific Corporation | LUX-Dx Insertable Cardiac Monitor (Device) | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: LUX-Dx_CRM | ||||||
| 04/30/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/08/2024 | BIOTRONIK INC. | AMVIA EDGE (Device) | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/22/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $6.44 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/08/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $97.69 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/09/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Cardiology | ||||||
| 08/24/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $6.15 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/23/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: Cardiology | ||||||
| 06/01/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: Cardiology | ||||||
| 05/05/2023 | Boston Scientific Corporation | LUX-Dx Insertable Cardiac Monitor (Device) | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: LUX-Dx_CRM | ||||||
| 04/22/2023 | Boston Scientific Corporation | LUX-Dx Insertable Cardiac Monitor (Device) | Food and Beverage | In-kind items and services | $166.26 | General |
| Category: LUX-Dx_CRM | ||||||
| 03/27/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/23/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $22.88 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/22/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/07/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: Cardiology | ||||||
| 03/06/2023 | SANOFI-AVENTIS U.S. LLC | MULTAQ (Drug) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/02/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $32.56 | General |
| Category: DIABETES | ||||||
| 02/22/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $24.63 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/23/2023 | SANOFI-AVENTIS U.S. LLC | MULTAQ (Drug) | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/19/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $10.17 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/18/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/09/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $22.11 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/29/2022 | Abbott Laboratories | MINI TREK (Device) | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: Vascular | ||||||
| 12/14/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $7.89 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 34 | 4,503 | 9,920 | $1.2M | $433,347 |
| 2022 | 39 | 4,882 | 13,826 | $1.4M | $546,438 |
| 2021 | 33 | 4,268 | 12,421 | $1.3M | $470,894 |
| 2020 | 32 | 3,799 | 10,135 | $1.1M | $404,667 |
Total Patients
17,452
Total Services
46,302
Medicare Billing
$1.9M
Procedure Codes
151
All Medicare Procedures & Services
151 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 807 | 1,377 | $351,412 | $120,629 | 34.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 392 | 957 | $150,041 | $58,667 | 39.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 232 | 259 | $93,207 | $32,407 | 34.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 608 | 621 | $85,039 | $31,197 | 36.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 238 | 239 | $92,241 | $31,074 | 33.7% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 85 | 85 | $72,755 | $27,342 | 37.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 263 | 285 | $75,873 | $27,138 | 35.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 132 | 236 | $54,600 | $21,747 | 39.8% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 85 | 168 | $38,368 | $14,664 | 38.2% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 75 | 75 | $45,569 | $13,503 | 29.6% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 140 | 140 | $21,376 | $7,741 | 36.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 62 | 62 | $20,760 | $7,594 | 36.6% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 65 | 95 | $14,946 | $5,407 | 36.2% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 79 | 80 | $11,156 | $3,716 | 33.3% |
| 93284 | Programming of multiple lead implantable defibrillator system | Office | 2023 | 22 | 38 | $7,945 | $2,912 | 36.7% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 84 | 167 | $7,608 | $2,488 | 32.7% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 12 | 14 | $6,109 | $2,314 | 37.9% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 54 | 113 | $6,830 | $2,254 | 33.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 241 | 306 | $5,446 | $1,905 | 35.0% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 20 | 70 | $6,090 | $1,788 | 29.4% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 110 | 110 | $4,666 | $1,679 | 36.0% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 19 | 19 | $4,057 | $1,572 | 38.7% |
| J0153 | Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | Office | 2023 | 64 | 3,687 | $7,196 | $1,517 | 21.1% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 32 | 54 | $6,318 | $1,464 | 23.2% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 135 | 135 | $3,803 | $1,405 | 36.9% |
About Dr. Leonard Grecul, MD
Dr. Leonard Grecul, MD is a Cardiovascular Disease healthcare provider based in Palm Bay, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1164412284.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Leonard Grecul, MD has received a total of $71,608 in payments from pharmaceutical and medical device companies, with $166.96 received in 2024. These payments were reported across 654 transactions from 27 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($57,550).
As a Medicare-enrolled provider, Grecul has provided services to 17,452 Medicare beneficiaries, totaling 46,302 services with total Medicare billing of $1.9M. Data is available for 4 years (2020–2023), covering 151 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Palm Bay, FL
- Active Since 10/28/2005
- Last Updated 01/17/2024
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1164412284
Products in Payments
- XARELTO (Drug) $50,166
- PRADAXA (Drug) $12,946
- ENTRESTO (Drug) $938.36
- ELIQUIS (Drug) $498.86
- JARDIANCE (Drug) $438.15
- Repatha (Biological) $390.07
- MitraClip System (Device) $275.80
- MULTAQ (Drug) $264.66
- CHANTIX (Drug) $264.45
- Claria MRI (Device) $241.48
- Cobalt (Device) $223.40
- LUX-Dx Insertable Cardiac Monitor (Device) $207.13
- LifeVest (Device) $168.87
- Micra (Device) $148.06
- Acticor 7 VR-T DX (Device) $146.80
- VERQUVO (Drug) $141.84
- WATCHMAN Access System (Device) $138.64
- ZIO Patch (Device) $131.57
- FARXIGA (Drug) $130.47
- MITRACLIP (Device) $128.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.